- Vienna '18
- Athens 2019
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
First Author: A.Grzybowski POLAND
Co Author(s): K. Kupidura-Majewski
Back to previous
The objective of this work was to evaluate the results of studies presenting the results of cataract surgeries in patients continuing antiplatelet and/or anticoagulant treatment.
The number of elderly patients using anticoagulant and antiplatelet treatment in the prevention of venous thromboembolism has significantly increased in recent years. It was believed for many years that those patients may be at a higher risk of complications during ocular surgery. Various strategies were thus proposed to prevent those complications, including anticoagulants discontinuation, dose reduction, or low molecular weight heparin replacement.
We performed a PubMed search of a possible intraoperative and postoperative complications in patients receiving anticoagulant and/or antiplatelet therapy in cataract surgery in years 2007-2012. We have searched for prospective and retrospective studies and case reports. We selected English and German language articles. Finally, we analyzed 8 articles related to cataract surgery and selected data that included surgical technique, anticoagulant and/or antiplatelet use, and intra- and postoperative complications.
No significant increase of intraoperative and postoperative complication risk during cataract surgery has been identified.
We conclude that the available data suggests that there is no need to discontinue anticoagulant and/or antiplatelet therapy before cataract surgery.